Standards for the Socioeconomic Evaluation of Health Care Services
Over the past decades, health care delivery - once characterized by clearly defined relationships between medical professionals, regulators, and industr- has become much more complex. Traditional roles and relationships are changing and new decision-makers are entering the scene. They bring into the...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Weitere Verfasser: | |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1990
|
| Schriftenreihe: | Health Systems Research
|
| Schlagworte: | |
| Online-Zugang: | DE-355 URL des Erstveröffentlichers |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046144455 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1990 xx o|||| 00||| eng d | ||
| 020 | |a 9783642754906 |9 978-3-642-75490-6 | ||
| 024 | 7 | |a 10.1007/978-3-642-75490-6 |2 doi | |
| 035 | |a (ZDB-2-SME)978-3-642-75490-6 | ||
| 035 | |a (OCoLC)1119088599 | ||
| 035 | |a (DE-599)BVBBV046144455 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 610 |2 23 | |
| 084 | |a QX 700 |0 (DE-625)142186: |2 rvk | ||
| 100 | 1 | |a Luce, Bryan R. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Standards for the Socioeconomic Evaluation of Health Care Services |c by Bryan R. Luce, Anne Elixhauser ; edited by A. J. Culyer |
| 264 | 1 | |a Berlin, Heidelberg |b Springer Berlin Heidelberg |c 1990 | |
| 300 | |a 1 Online-Ressource (XV, 184 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Health Systems Research | |
| 520 | |a Over the past decades, health care delivery - once characterized by clearly defined relationships between medical professionals, regulators, and industr- has become much more complex. Traditional roles and relationships are changing and new decision-makers are entering the scene. They bring into the discussion the need for cost containment and the changing perceptions of the public with regard to the risks and benefits of health care outcomes. As benefits of medical care are increasingly questioned and as scepticism and fear of advanced technologies are demonstrated by a growing body of people, decision making must move beyond medical concerns to encompass economic, political, and sociological considera tions. This evolution has also affected the pharmaceutical industry. Public percep tion of responsibility for product safety is no longer limited to regulators and physi cians. Manufacturers, previously unencumbered by social policies, governmental preoccupations, or public expectations, are now held accountable for product safety. As a certain amount of risk acceptance is, however, a prerequisite for the further development of health care goods, it has to be carefully balanced against society'S demand for safety. To weigh risks against benefits, to define acceptable risk, and to exclude what no longer falls within this category remain perpetual challenges. Accordingly, health care outcomes have to be assessed not only from a clinical point of view, but also from an economic and societal perspective. The assessment of drug risks and benefits has become an important political issue world-wide | ||
| 650 | 4 | |a Medicine/Public Health, general | |
| 650 | 4 | |a Statistics for Life Sciences, Medicine, Health Sciences | |
| 650 | 4 | |a Medicine | |
| 650 | 4 | |a Statistics | |
| 650 | 0 | 7 | |a Gesundheitsvorsorge |0 (DE-588)4136584-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitswesen |0 (DE-588)4020775-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Evaluation |0 (DE-588)4071034-8 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Gesundheitsvorsorge |0 (DE-588)4136584-7 |D s |
| 689 | 0 | 1 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Gesundheitswesen |0 (DE-588)4020775-4 |D s |
| 689 | 1 | 1 | |a Evaluation |0 (DE-588)4071034-8 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Elixhauser, Anne |4 aut | |
| 700 | 1 | |a Culyer, A. J. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642754920 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783540522645 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642754913 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-642-75490-6 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-031524640 | |
| 966 | e | |u https://doi.org/10.1007/978-3-642-75490-6 |l DE-355 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1819307122422185984 |
|---|---|
| any_adam_object | |
| author | Luce, Bryan R. Elixhauser, Anne |
| author2 | Culyer, A. J. |
| author2_role | edt |
| author2_variant | a j c aj ajc |
| author_facet | Luce, Bryan R. Elixhauser, Anne Culyer, A. J. |
| author_role | aut aut |
| author_sort | Luce, Bryan R. |
| author_variant | b r l br brl a e ae |
| building | Verbundindex |
| bvnumber | BV046144455 |
| classification_rvk | QX 700 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-3-642-75490-6 (OCoLC)1119088599 (DE-599)BVBBV046144455 |
| dewey-full | 610 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 610 - Medicine and health |
| dewey-raw | 610 |
| dewey-search | 610 |
| dewey-sort | 3610 |
| dewey-tens | 610 - Medicine and health |
| discipline | Wirtschaftswissenschaften Medizin |
| doi_str_mv | 10.1007/978-3-642-75490-6 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03931nam a2200601zc 4500</leader><controlfield tag="001">BV046144455</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1990 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642754906</subfield><subfield code="9">978-3-642-75490-6</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-642-75490-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-642-75490-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119088599</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046144455</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QX 700</subfield><subfield code="0">(DE-625)142186:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Luce, Bryan R.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Standards for the Socioeconomic Evaluation of Health Care Services</subfield><subfield code="c">by Bryan R. Luce, Anne Elixhauser ; edited by A. J. Culyer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin, Heidelberg</subfield><subfield code="b">Springer Berlin Heidelberg</subfield><subfield code="c">1990</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XV, 184 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Health Systems Research</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Over the past decades, health care delivery - once characterized by clearly defined relationships between medical professionals, regulators, and industr- has become much more complex. Traditional roles and relationships are changing and new decision-makers are entering the scene. They bring into the discussion the need for cost containment and the changing perceptions of the public with regard to the risks and benefits of health care outcomes. As benefits of medical care are increasingly questioned and as scepticism and fear of advanced technologies are demonstrated by a growing body of people, decision making must move beyond medical concerns to encompass economic, political, and sociological considera tions. This evolution has also affected the pharmaceutical industry. Public percep tion of responsibility for product safety is no longer limited to regulators and physi cians. Manufacturers, previously unencumbered by social policies, governmental preoccupations, or public expectations, are now held accountable for product safety. As a certain amount of risk acceptance is, however, a prerequisite for the further development of health care goods, it has to be carefully balanced against society'S demand for safety. To weigh risks against benefits, to define acceptable risk, and to exclude what no longer falls within this category remain perpetual challenges. Accordingly, health care outcomes have to be assessed not only from a clinical point of view, but also from an economic and societal perspective. The assessment of drug risks and benefits has become an important political issue world-wide</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine/Public Health, general</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Statistics for Life Sciences, Medicine, Health Sciences</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Statistics</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitsvorsorge</subfield><subfield code="0">(DE-588)4136584-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitswesen</subfield><subfield code="0">(DE-588)4020775-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Evaluation</subfield><subfield code="0">(DE-588)4071034-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Gesundheitsvorsorge</subfield><subfield code="0">(DE-588)4136584-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Gesundheitswesen</subfield><subfield code="0">(DE-588)4020775-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Evaluation</subfield><subfield code="0">(DE-588)4071034-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Elixhauser, Anne</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Culyer, A. J.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642754920</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783540522645</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642754913</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-642-75490-6</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031524640</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-642-75490-6</subfield><subfield code="l">DE-355</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV046144455 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-24T07:47:56Z |
| institution | BVB |
| isbn | 9783642754906 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031524640 |
| oclc_num | 1119088599 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XV, 184 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1990 |
| publishDateSearch | 1990 |
| publishDateSort | 1990 |
| publisher | Springer Berlin Heidelberg |
| record_format | marc |
| series2 | Health Systems Research |
| spelling | Luce, Bryan R. Verfasser aut Standards for the Socioeconomic Evaluation of Health Care Services by Bryan R. Luce, Anne Elixhauser ; edited by A. J. Culyer Berlin, Heidelberg Springer Berlin Heidelberg 1990 1 Online-Ressource (XV, 184 p) txt rdacontent c rdamedia cr rdacarrier Health Systems Research Over the past decades, health care delivery - once characterized by clearly defined relationships between medical professionals, regulators, and industr- has become much more complex. Traditional roles and relationships are changing and new decision-makers are entering the scene. They bring into the discussion the need for cost containment and the changing perceptions of the public with regard to the risks and benefits of health care outcomes. As benefits of medical care are increasingly questioned and as scepticism and fear of advanced technologies are demonstrated by a growing body of people, decision making must move beyond medical concerns to encompass economic, political, and sociological considera tions. This evolution has also affected the pharmaceutical industry. Public percep tion of responsibility for product safety is no longer limited to regulators and physi cians. Manufacturers, previously unencumbered by social policies, governmental preoccupations, or public expectations, are now held accountable for product safety. As a certain amount of risk acceptance is, however, a prerequisite for the further development of health care goods, it has to be carefully balanced against society'S demand for safety. To weigh risks against benefits, to define acceptable risk, and to exclude what no longer falls within this category remain perpetual challenges. Accordingly, health care outcomes have to be assessed not only from a clinical point of view, but also from an economic and societal perspective. The assessment of drug risks and benefits has become an important political issue world-wide Medicine/Public Health, general Statistics for Life Sciences, Medicine, Health Sciences Medicine Statistics Gesundheitsvorsorge (DE-588)4136584-7 gnd rswk-swf Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd rswk-swf Gesundheitswesen (DE-588)4020775-4 gnd rswk-swf Evaluation (DE-588)4071034-8 gnd rswk-swf Gesundheitsvorsorge (DE-588)4136584-7 s Kosten-Nutzen-Analyse (DE-588)4032589-1 s DE-604 Gesundheitswesen (DE-588)4020775-4 s Evaluation (DE-588)4071034-8 s Elixhauser, Anne aut Culyer, A. J. edt Erscheint auch als Druck-Ausgabe 9783642754920 Erscheint auch als Druck-Ausgabe 9783540522645 Erscheint auch als Druck-Ausgabe 9783642754913 https://doi.org/10.1007/978-3-642-75490-6 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Luce, Bryan R. Elixhauser, Anne Standards for the Socioeconomic Evaluation of Health Care Services Medicine/Public Health, general Statistics for Life Sciences, Medicine, Health Sciences Medicine Statistics Gesundheitsvorsorge (DE-588)4136584-7 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Gesundheitswesen (DE-588)4020775-4 gnd Evaluation (DE-588)4071034-8 gnd |
| subject_GND | (DE-588)4136584-7 (DE-588)4032589-1 (DE-588)4020775-4 (DE-588)4071034-8 |
| title | Standards for the Socioeconomic Evaluation of Health Care Services |
| title_auth | Standards for the Socioeconomic Evaluation of Health Care Services |
| title_exact_search | Standards for the Socioeconomic Evaluation of Health Care Services |
| title_full | Standards for the Socioeconomic Evaluation of Health Care Services by Bryan R. Luce, Anne Elixhauser ; edited by A. J. Culyer |
| title_fullStr | Standards for the Socioeconomic Evaluation of Health Care Services by Bryan R. Luce, Anne Elixhauser ; edited by A. J. Culyer |
| title_full_unstemmed | Standards for the Socioeconomic Evaluation of Health Care Services by Bryan R. Luce, Anne Elixhauser ; edited by A. J. Culyer |
| title_short | Standards for the Socioeconomic Evaluation of Health Care Services |
| title_sort | standards for the socioeconomic evaluation of health care services |
| topic | Medicine/Public Health, general Statistics for Life Sciences, Medicine, Health Sciences Medicine Statistics Gesundheitsvorsorge (DE-588)4136584-7 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Gesundheitswesen (DE-588)4020775-4 gnd Evaluation (DE-588)4071034-8 gnd |
| topic_facet | Medicine/Public Health, general Statistics for Life Sciences, Medicine, Health Sciences Medicine Statistics Gesundheitsvorsorge Kosten-Nutzen-Analyse Gesundheitswesen Evaluation |
| url | https://doi.org/10.1007/978-3-642-75490-6 |
| work_keys_str_mv | AT lucebryanr standardsforthesocioeconomicevaluationofhealthcareservices AT elixhauseranne standardsforthesocioeconomicevaluationofhealthcareservices AT culyeraj standardsforthesocioeconomicevaluationofhealthcareservices |